Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • HCG to increase stake...

    HCG to increase stake in BACC Healthcare; stocks gain 2%

    GarimaWritten by Garima Published On 2019-02-11T16:06:07+05:30  |  Updated On 11 Feb 2019 4:06 PM IST
    HCG to increase stake in BACC Healthcare; stocks gain 2%
    Shares of HealthCare Global Enterprises (HCG) gained 2% on Friday after the company, in its filing to the exchanges, informed that it will increase its stake from 50.1% to 100% in its arm BACC Healthcare.


    The company currently holds 50.1% of the share capital of BACC, which it acquired in March 2013, HCG said in a press note after market hours to the exchanges. Accordingly, the company shall acquire the remaining 46,695 equity shares, constituting 49.9% of the share capital of BACC from
    Dr. Kamini A. Rao, the company added.



    BACC operates fertility treatment centers under the brand Milann. Dr. Rao will continue to serve as the Medical Director of Milann, the company added.

    Healthcare Global Enterprises Ltd's share price is currently trading at Rs193.40, up by Rs4.45 or 2.36%, from its previous closing of Rs188.95 on the BSE.

    The scrip opened at Rs187 and has touched a high and low of Rs201 and Rs187, respectively. So far 6,610 (NSE+BSE) shares have been traded on the counter. The current market cap of the company is Rs1,660.65cr.

    BACC HealthcareDr Kamini A RaoHCGHealthcare Global EnterprisesMilann Dr RaoSharesstocks gain
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok